PAPER Hernandez-Candia CN, Brady BR, Harrison E, Tucker CL
SEARCH RESULTS
329663 RESULTS
PAPER Gordón Pidal JM, Moreno-Guzmán M, Montero-Calle A, Valverde A, Pingarrón JM, Campuzano S, Calero M, Barderas R, López MÁ, Escarpa A
Micromotor-based electrochemical immunoassays for reliable determination of amyloid-β (1-42) in Alzheimer's diagnosed clinical samples.
Biosens Bioelectron. 2024 Apr 1;249:115988. Epub 2023 Dec 31 PubMed: 38194814PAPER Illes-Toth E, Rempel DL, Gross ML
Exploration of Resveratrol as a Potent Modulator of α-Synuclein Fibril Formation.
ACS Chem Neurosci. 2024 Feb 7;15(3):503-516. Epub 2024 Jan 9 PubMed: 38194353PAPER Kaleta M, Hényková E, Menšíková K, Friedecký D, Kvasnička A, Klíčová K, Koníčková D, Strnad M, Kaňovský P, Novák O
Patients with Neurodegenerative Proteinopathies Exhibit Altered Tryptophan Metabolism in the Serum and Cerebrospinal Fluid.
ACS Chem Neurosci. 2024 Feb 7;15(3):582-592. Epub 2024 Jan 9 PubMed: 38194490PAPER Qiang Q, Skudder-Hill L, Toyota T, Huang Z, Wei W, Adachi H, Alzheimer's Disease Neuroimaging Initiative
CSF 14-3-3 zeta(ζ) isoform is associated with tau pathology and cognitive decline in Alzheimer's disease.
J Neurol Sci. 2024 Feb 15;457:122861. Epub 2024 Jan 1 PubMed: 38194803PAPER Beveridge J, Kaniecki E, Naidu A, Silverglate BD, Grossberg G
How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer's disease?
Expert Opin Emerg Drugs. 2024 Mar;29(1):35-43. Epub 2024 Jan 12 PubMed: 38193477PAPER Toro-Hernández FD, Migeot J, Marchant N, Olivares D, Ferrante F, González-Gómez R, González Campo C, Fittipaldi S, Rojas-Costa GM, Moguilner S, Slachevsky A, Chaná Cuevas P, Ibáñez A, Chaigneau S, García AM
Neurocognitive correlates of semantic memory navigation in Parkinson's disease.
NPJ Parkinsons Dis. 2024 Jan 9;10(1):15. PubMed: 38195756PAPER Frank A, Bendig J, Schnalke N, Klingelhoefer L, Reichmann H, Akgün K, Ziemssen T, Falkenburger BH
Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson's disease.
NPJ Parkinsons Dis. 2024 Jan 9;10(1):14. PubMed: 38195715PAPER Montine KS, Berson E, Phongpreecha T, Huang Z, Aghaeepour N, Zou JY, MacCoss MJ, Montine TJ
Understanding the molecular basis of resilience to Alzheimer's disease.
Front Neurosci. 2023;17:1311157. Epub 2023 Dec 19 PubMed: 38192507PAPER Vemula P, Schoch KM, Miller TM
Evaluating the efficacy of purchased antisense oligonucleotides to reduce mouse and human tau in vivo.
Front Mol Neurosci. 2023;16:1320182. Epub 2023 Dec 18 PubMed: 38192302PAPER Alghusen IM, Carman MS, Wilkins H, Ephrame SJ, Qiang A, Dias WB, Fedosyuk H, Denson AR, Swerdlow RH, Slawson C
O-GlcNAc regulates the mitochondrial integrated stress response by regulating ATF4.
Front Aging Neurosci. 2023;15:1326127. Epub 2023 Dec 18 PubMed: 38192280PAPER Naaldijk Y, Fernández B, Fasiczka R, Fdez E, Leghay C, Croitoru I, Kwok JB, Boulesnane Y, Vizeneux A, Mutez E, Calvez C, Destée A, Taymans JM, Aragon AV, Yarza AB, Padmanabhan S, Delgado M, Alcalay RN, Chatterton Z, Dzamko N, Halliday G, Ruiz-Martínez J, Chartier-Harlin MC, Hilfiker S
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells.
NPJ Parkinsons Dis. 2024 Jan 8;10(1):12. PubMed: 38191886PAPER Neueder A, Kojer K, Gu Z, Wang Y, Hering T, Tabrizi S, Taanman JW, Orth M
Huntington disease affects mitochondrial network dynamics predisposing to pathogenic mtDNA mutations.
Brain. 2024 Jan 9; PubMed: 38195181Julie Harris
Cure Alzheimer's FundUnited States
Qiang Qiang
Fudan UniversityShanghai, China
Current Filters
- Date Range : All x